A. Sechi

发表

A Web-Based Decision Aid (myAID) to Enhance Quality of Life, Empowerment, Decision Making, and Disease Control for Patients With Ulcerative Colitis: Protocol for a Cluster Randomized Controlled Trial

J. Andrews, A. Kim, A. Girgis, 2020, JMIR research protocols.

Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications

D. Rubin, A. Girgis, A. Sechi, 2014, Inflammatory bowel diseases.

Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study (Preprint)

J. Andrews, A. Kim, A. Girgis, 2019 .

Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?

A. Sechi, S. Connor, G. Wark, 2021, World journal of gastroenterology.

Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views

A. Sechi, S. Connor, J. Deuring, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease

J. Andrews, G. Radford-Smith, A. Sechi, 2020, Scandinavian journal of gastroenterology.

Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response

J. Andrews, I. Lawrance, A. Sechi, 2015, Internal medicine journal.

A Web-Based Decision Aid (myAID) to Enhance Quality of Life, Empowerment, Decision Making, and Disease Control for Patients With Ulcerative Colitis: Protocol for a Cluster Randomized Controlled Trial (Preprint)

J. Andrews, A. Kim, A. Girgis, 2019 .

Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients

P. Bampton, A. Sechi, S. Connor, 2015, Internal medicine journal.

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

J. Andrews, P. Bampton, A. Sechi, 2022, Digestive Diseases and Sciences.

Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study

J. Andrews, P. Bampton, A. Sechi, 2015 .

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

J. Andrews, P. Bampton, R. Gearry, 2017, Alimentary pharmacology & therapeutics.

Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study

J. Andrews, A. Kim, A. Girgis, 2021, Journal of medical Internet research.

Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study

J. Andrews, P. Bampton, A. Sechi, 2015 .